<DOC>
	<DOCNO>NCT01947998</DOCNO>
	<brief_summary>This prospective cohort study provide information : characteristic Rivaroxaban use patient prescribe Rivaroxaban first time compare patient prescribe Warfarin first time , occurrence intracranial haemorrhage , gastrointestinal urogenital bleeding , occurrence non-infective liver disease .</brief_summary>
	<brief_title>Study Rivaroxaban Use Potential Adverse Outcomes Routine Clinical Pratice ( UK )</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients 2 89 year , prescribe first time either Rivaroxaban Warfarin .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rivaroxaban ,</keyword>
	<keyword>Pulmonary Embolism ,</keyword>
	<keyword>Venous Thrombosis ,</keyword>
	<keyword>Venous Thromboembolism ,</keyword>
	<keyword>Acute Coronary Syndrome ,</keyword>
	<keyword>Intracranial Hemorrhages ,</keyword>
	<keyword>Gastrointestinal Hemorrhage ,</keyword>
	<keyword>Warfarin</keyword>
</DOC>